HB744: Income Tax - Biotechnology Investment Incentive Tax Credit Program - Pass-Through Entities

Legislative Summary

Allowing a qualified investor that is a pass-through entity that pays a certain income tax on behalf of its members to receive and allocate in any manner a credit or refund of a credit under the Biotechnology Investment Incentive Tax Credit Program; applying the Act to all taxable years beginning after December 31, 2023; etc.